Want to join the conversation?
$VRTU expects 1Q17 revenue to be $202.5-207.5MM and non-GAAP diluted EPS to be $0.14-0.18. FY17 revenue is expected to be $890-920MM and non-GAAP diluted EPS is expected to be $2.10-2.30. The 1Q17 and FY17 diluted EPS estimates an avg. share count of approx. 30.1MM and 30.3MM, respectively, and assumes a stock price of $35.88.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)